Humanized anti-CCR2 antibodies and methods of use thereof
Details for Australian Patent Application No. 2009201216 (hide)
International Classifications
Event Publications
23 April 2009 Application Open to Public Inspection
Published as AU-A-2009201216
23 April 2009 Complete Application Filed
30 April 2009 Corrigenda
Applications OPI - Name Index Under the name Millennium Pharmaceuticals, Inc., Application No. 2009201216, under INID (54) correct the title to read Humanized anti-CCR2 antibodies and methods of use therefor.
25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009201217-Disposable working electrode for an electochemical cell
2009201215-A method of gaming, a gaming system and a game controller
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser